230 related articles for article (PubMed ID: 16781841)
1. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
Kaufmann W; Gröters S
Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
[TBL] [Abstract][Full Text] [Related]
2. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
3. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
4. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
[TBL] [Abstract][Full Text] [Related]
5. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
6. The underestimated value of OECD 421 and 422 repro screening studies: putting it in the right perspective.
Beekhuijzen M; de Raaf MA; Zmarowski A; van Otterdijk F; Peter B; Emmen H
Reprod Toxicol; 2014 Sep; 48():81-7. PubMed ID: 24768663
[TBL] [Abstract][Full Text] [Related]
7. SIDS reprotoxicity screening test update: testing strategies and use.
Gelbke HP; Fleig H; Meder M;
Regul Toxicol Pharmacol; 2004 Apr; 39(2):81-6. PubMed ID: 15041141
[TBL] [Abstract][Full Text] [Related]
8. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Holson RR; Freshwater L; Maurissen JP; Moser VC; Phang W
Neurotoxicol Teratol; 2008; 30(4):326-48. PubMed ID: 17681748
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
[TBL] [Abstract][Full Text] [Related]
11. Testing methods for developmental neurotoxicity of environmental chemicals.
Claudio L; Kwa WC; Russell AL; Wallinga D
Toxicol Appl Pharmacol; 2000 Apr; 164(1):1-14. PubMed ID: 10739739
[TBL] [Abstract][Full Text] [Related]
12. Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
Kuwagata M
Congenit Anom (Kyoto); 2012 Sep; 52(3):129-39. PubMed ID: 22925213
[TBL] [Abstract][Full Text] [Related]
13. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK
Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700
[TBL] [Abstract][Full Text] [Related]
14. Developmental neurotoxicology.
Bondy SC; Campbell A
J Neurosci Res; 2005 Sep; 81(5):605-12. PubMed ID: 16035107
[TBL] [Abstract][Full Text] [Related]
15. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
[TBL] [Abstract][Full Text] [Related]
16. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
Pohl HR; Smith-Simon C; Hicks H
Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
[TBL] [Abstract][Full Text] [Related]
17. Neurospheres as a model for developmental neurotoxicity testing.
Fritsche E; Gassmann K; Schreiber T
Methods Mol Biol; 2011; 758():99-114. PubMed ID: 21815061
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F
Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050
[TBL] [Abstract][Full Text] [Related]
19. Expanding the test set: Chemicals with potential to disrupt mammalian brain development.
Mundy WR; Padilla S; Breier JM; Crofton KM; Gilbert ME; Herr DW; Jensen KF; Radio NM; Raffaele KC; Schumacher K; Shafer TJ; Cowden J
Neurotoxicol Teratol; 2015; 52(Pt A):25-35. PubMed ID: 26476195
[TBL] [Abstract][Full Text] [Related]
20. Bromate: concern for developmental neurotoxicity?
Crofton KM
Toxicology; 2006 Apr; 221(2-3):212-6. PubMed ID: 16516369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
